GlaxoSmithKline Current Ratio 2006-2018 | GSK

Historical current ratio values for GlaxoSmithKline (GSK) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.564B $38.892B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.390B 16.55
Pfizer (PFE) United States $224.125B 13.79
Novartis AG (NVS) Switzerland $182.384B 15.80
Merck (MRK) United States $168.593B 15.07
AbbVie (ABBV) United States $151.404B 15.44
Novo Nordisk (NVO) Denmark $122.519B 20.30
Sanofi (SNY) France $105.189B 13.31
Eli Lilly (LLY) United States $97.222B 19.30
AstraZeneca (AZN) United Kingdom $94.148B 9.86
Bristol-Myers Squibb (BMY) United States $92.564B 18.21